Centricity Wealth Management LLC Makes New Investment in iShares Biotechnology ETF (NASDAQ:IBB)

Centricity Wealth Management LLC bought a new position in iShares Biotechnology ETF (NASDAQ:IBB) in the fourth quarter, according to its most recent disclosure with the SEC. The firm bought 415 shares of the financial services provider’s stock, valued at approximately $55,000.

A number of other hedge funds and other institutional investors have also modified their holdings of IBB. Sequoia Financial Advisors LLC increased its holdings in shares of iShares Biotechnology ETF by 8.3% during the 3rd quarter. Sequoia Financial Advisors LLC now owns 2,608 shares of the financial services provider’s stock worth $380,000 after buying an additional 199 shares during the last quarter. Eastern Bank purchased a new stake in iShares Biotechnology ETF in the third quarter valued at $65,000. Lyell Wealth Management LP lifted its stake in shares of iShares Biotechnology ETF by 3.4% in the 3rd quarter. Lyell Wealth Management LP now owns 22,274 shares of the financial services provider’s stock valued at $3,243,000 after purchasing an additional 735 shares during the last quarter. NorthCrest Asset Manangement LLC grew its holdings in shares of iShares Biotechnology ETF by 12.3% during the 3rd quarter. NorthCrest Asset Manangement LLC now owns 3,290 shares of the financial services provider’s stock worth $479,000 after purchasing an additional 360 shares during the period. Finally, Riggs Asset Managment Co. Inc. increased its position in shares of iShares Biotechnology ETF by 1,314.0% during the 3rd quarter. Riggs Asset Managment Co. Inc. now owns 1,513 shares of the financial services provider’s stock worth $220,000 after purchasing an additional 1,406 shares during the last quarter. 62.45% of the stock is owned by institutional investors and hedge funds.

iShares Biotechnology ETF Stock Performance

Shares of IBB opened at $138.91 on Friday. The company’s 50-day moving average price is $135.61 and its 200 day moving average price is $140.77. iShares Biotechnology ETF has a 12-month low of $123.60 and a 12-month high of $150.57.

iShares Biotechnology ETF Cuts Dividend

The business also recently declared a dividend, which was paid on Friday, December 20th. Stockholders of record on Tuesday, December 17th were paid a $0.0624 dividend. The ex-dividend date was Tuesday, December 17th.

iShares Biotechnology ETF Company Profile

iShares Nasdaq Biotechnology ETF (the Fund), formerly iShares Nasdaq Biotechnology Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the NASDAQ Biotechnology Index (the Index). The Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals, which also meet other eligibility criteria determined by NASDAQ.